Second Sight Medical Products, Inc. (EYES) financial statements (2021 and earlier)

Company profile

Business Address 12744 SAN FERNANDO ROAD, BLDG. 3
SYLMAR, CA 91342
State of Incorp. CA
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments311481116
Cash and cash equivalents31148110
Short-term investments     16
Receivables 01202
Inventory, net of allowances, customer advances and progress billings 13338
Inventory 13338
Other undisclosed current assets101111
Total current assets:41310131527
Noncurrent Assets
Operating lease, right-of-use asset 2
Property, plant and equipment011111
Deposits noncurrent assets     0
Other undisclosed noncurrent assets00000 
Total noncurrent assets:031121
TOTAL ASSETS:41711141728
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities266653
Accounts payable011111
Accrued liabilities123222
Employee-related liabilities03332 
Deferred revenue00
Debt20    
Deferred revenue and credits000
Contract with customer, liability0
Other undisclosed current liabilities111115
Total current liabilities:578768
Noncurrent Liabilities
Long-term debt and lease obligation 2    
Operating lease, liability 2
Total noncurrent liabilities: 2    
Total liabilities:598768
Stockholders' equity
Stockholders' equity attributable to parent, including:(1)7381120
Common stock270264229202187166
Additional paid in capital494944413127
Accumulated other comprehensive loss(0)(1)(1)(1)(1)(1)
Accumulated deficit(320)(305)(269)(234)(206)(173)
Receivable from shareholders or affiliates for issuance of capital stock     (0)
Warrants and rights outstanding    1,038 
Other undisclosed stockholders' equity attributable to parent   0(1,038)0
Total stockholders' equity:(1)7381120
TOTAL LIABILITIES AND EQUITY:41711141728

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues037849
Revenue, net84 
Net investment income00000 
Cost of revenue(1)(2)(5)(5)(10)(5)
Cost of goods and services sold(1)(2)(5)(5)(10)(0)
Other undisclosed gross profit1   (0) 
Gross profit:1123(6)4
Operating expenses(15)(35)(37)(31)(27)(24)
Operating loss:(15)(34)(35)(29)(33)(20)
Nonoperating income
(Other Nonoperating income)
     0
Net loss:(15)(34)(35)(29)(33)(20)
Other undisclosed net income attributable to parent000000
Net loss available to common stockholders, diluted:(15)(34)(35)(29)(33)(20)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(15)(34)(35)(29)(33)(20)
Other comprehensive loss    (33)(20)
Comprehensive loss:(15)(34)(35)(29)(66)(40)
Other undisclosed comprehensive income, net of tax, attributable to parent00003320
Comprehensive loss, net of tax, attributable to parent:(15)(34)(35)(28)(33)(20)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: